Results

Fortress Biotech Inc.

11/04/2024 | Press release | Distributed by Public on 11/04/2024 06:08

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea